Brief: Selvita Receives EUR 1.3 Mln Order From European Biopharmaceutical Company
02/04/2026 07:22
April 2 (Reuters) - Selvita SA SLV1.WA: RECEIVES PURCHASE ORDER FROM EUROPEAN BIOPHARMACEUTICAL COMPANY ORDER EXTENDS COOPERATION WITH CLIENT UNTIL FEBRUARY 28, 2027 ORDER VALUE IS EUR 1.3 MILLION ORDER COVERS DESIGN, SYNTHESIS AND EVALUATION OF NEW CHEMICAL COMPOUNDS Source text: ID:nEM8d0fNva Further company coverage: SLV1.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Selvita SA
See all newsBrief: Selvita Units Selvita Services And Pozlab Sign Merger Plan
Brief: Selvita Appoints Rafal Chwast As CEO
Brief: Selvita Q2 Net Loss At 3.0 Mln Zlotys
Brief: Selvita Receives Significant Order From European Biopharmaceutical Company Worth Up to €5 Million
Brief: Selvita Q1 Net Loss At 5.5 Million Zlotys